ArticleCurrent cancer drug targets2025

PLCG2, A Regulator of Lung Adenocarcinoma Proliferation and Migration Associated with Immune Infiltration.

Shuhui Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.